Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression.


Journal

Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230

Informations de publication

Date de publication:
01 2022
Historique:
revised: 16 07 2021
received: 12 04 2021
accepted: 10 08 2021
pubmed: 12 8 2021
medline: 9 4 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

In some tumors, a small number of cancer cells are scattered in a large fibrotic stroma. Here, we demonstrate a novel mechanism for expansion of pro-tumor fibroblasts via cancer-associated fibroblast (CAF)-mediated education of normal fibroblasts (NFs). When NFs were incubated with conditioned medium from CAFs, the resulting CAF-educated fibroblasts (CEFs) generated reactive oxygen species, which induced NF-κB-mediated expression of inflammatory cytokines and the extracellular matrix protein asporin (ASPN), while expression of a common CAF marker gene, α-SMA, was not increased. ASPN further increased CEF expression of downstream molecules, including indoleamine 2,3-dioxygenase 1 (IDO-1), kynureninase (KYNU), and pregnancy-associated plasma protein-A (PAPP-A). These CEFs induce cytocidal effects against CD8

Identifiants

pubmed: 34379869
doi: 10.1002/1878-0261.13077
pmc: PMC8732346
doi:

Substances chimiques

Extracellular Matrix Proteins 0

Banques de données

RefSeq
['NM_017680']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-187

Informations de copyright

© 2021 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

Sci Rep. 2017 Jun 23;7(1):4112
pubmed: 28646230
Front Cell Dev Biol. 2020 Jul 15;8:630
pubmed: 32760726
Br J Cancer. 2010 Mar 2;102(5):898-907
pubmed: 20145613
Oncotarget. 2016 May 10;7(19):27584-98
pubmed: 27050278
Oxid Med Cell Longev. 2016;2016:3907147
pubmed: 26798421
J Cell Mol Med. 2021 Mar;25(5):2309-2314
pubmed: 33486887
Pharmacol Ther. 2018 Mar;183:22-33
pubmed: 28942242
Cancer Cell. 2011 Feb 15;19(2):257-72
pubmed: 21316604
Blood. 2004 Jun 15;103(12):4619-21
pubmed: 15001472
Int J Tryptophan Res. 2016 Oct 12;9:67-77
pubmed: 27773992
Breast Cancer Res. 2020 Oct 27;22(1):113
pubmed: 33109232
Cancer Res. 2012 Nov 15;72(22):5649-57
pubmed: 23144293
Carcinogenesis. 2008 Apr;29(4):713-21
pubmed: 18258605
Proteomics. 2019 Apr;19(8):e1800148
pubmed: 30582284
Nat Commun. 2018 Dec 4;9(1):5150
pubmed: 30514914
Nat Commun. 2018 May 3;9(1):1777
pubmed: 29725014
Transpl Int. 2005 Jan;18(1):95-100
pubmed: 15612990
Br J Pharmacol. 2017 Jun;174(12):1533-1554
pubmed: 28332701
Oncogene. 2019 Jul;38(28):5566-5579
pubmed: 31147602
Cell Death Differ. 2002 Oct;9(10):1069-77
pubmed: 12232795
Clin Exp Metastasis. 2019 Apr;36(2):71-86
pubmed: 30847799
Cancer Sci. 2005 Jun;96(6):323-32
pubmed: 15958054
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
Oncotarget. 2016 Aug 9;7(32):52045-52060
pubmed: 27409832
Int J Cancer. 2016 Mar 1;138(5):1058-66
pubmed: 25784597
Clin Transl Oncol. 2021 Feb;23(2):418-423
pubmed: 32533317
Cancers (Basel). 2018 Oct 29;10(11):
pubmed: 30380628
J Exp Med. 2005 Jan 3;201(1):105-15
pubmed: 15630139
J Cell Biol. 2014 Jul 7;206(1):113-27
pubmed: 25002680
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Cancer Res. 2007 Nov 15;67(22):11045-53
pubmed: 18006851
Mol Cancer Ther. 2009 Jan;8(1):261-73
pubmed: 19139136
Oncogene. 2019 Jun;38(25):4887-4901
pubmed: 30816343
World J Gastroenterol. 2014 Dec 21;20(47):17804-18
pubmed: 25548479
Cancer Lett. 2017 Jul 10;398:24-36
pubmed: 28400334
Ann Endocrinol (Paris). 2016 Jun;77(2):90-6
pubmed: 27155776
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
J Immunol. 2010 Sep 15;185(6):3190-8
pubmed: 20720200
Nat Genet. 2017 May;49(5):708-718
pubmed: 28319088
J Exp Clin Cancer Res. 2020 Jun 16;39(1):112
pubmed: 32546182
Br J Pharmacol. 2019 Feb;176(3):337-354
pubmed: 30381825
Oncogene. 2015 Jan 29;34(5):650-60
pubmed: 24441039
Cancer Sci. 2021 Mar;112(3):1251-1261
pubmed: 33393151
Br J Cancer. 2017 Mar 14;116(6):775-784
pubmed: 28152543
Cell Cycle. 2010 Sep 1;9(17):3515-33
pubmed: 20855962
Hypertension. 2015 Dec;66(6):1220-6
pubmed: 26483345
Sci Rep. 2018 Mar 1;8(1):3888
pubmed: 29497093
Biochem Biophys Res Commun. 2003 Sep 12;309(1):232-40
pubmed: 12943687
Br J Cancer. 2011 Sep 27;105(7):996-1001
pubmed: 21863023
PLoS One. 2012;7(11):e48799
pubmed: 23152806
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):467-473
pubmed: 27605398
Cancer Res. 2019 Oct 15;79(20):5367-5381
pubmed: 31439548

Auteurs

Go Itoh (G)

Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Japan.

Kurara Takagane (K)

Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Japan.

Yuma Fukushi (Y)

Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Japan.
Department of Life Science, Faculty and Graduate School of Engineering and Resource Science, Akita University, Japan.

Sei Kuriyama (S)

Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Japan.

Michinobu Umakoshi (M)

Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Japan.

Akiteru Goto (A)

Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Japan.

Kazuyoshi Yanagihara (K)

Division of Biomarker Discovery, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan.

Masakazu Yashiro (M)

Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Japan.

Masamitsu Tanaka (M)

Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH